Clear cell adenocarcinoma of the uterine cervix [9]

Taiwanese Journal of Obstetrics and Gynecology

Volumn 46, Issue 4, 2007, Pages 453-455

  Chen, Chun Wei ^a   Hsiao, Hseng Mou ^a   Chen, Chi An ^a   Hsieh, Chang Yao ^a   Cheng, Wen Fang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADENOCARCINOMA; ADULT; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; LETTER; LYMPH NODE DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPANICOLAOU TEST; PUNCH BIOPSY; SALPINGOOOPHORECTOMY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA;

EID: 38049064352     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(08)90024-3     Document Type: Article

References (18)

1. Altekruse SF, Lacey JV Jr, Brinton LAA, et al. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am J Obstet Gynecol 2003;188:657-63.
2. Iwasawa A, Nieminen P, Lehtinen M, Paavonen J. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer 1996;77:2275-9.
3. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352-7.
4. Grigsby PW, Perez CA, Kuske RR, Camel HM, Kao MS, Galakatos AE, Hederman MA. Adenocarcinoma of the uterine cervix: lack of evidence for a poor prognosis. Radiother Oncol 1988;12:289-96.
5. Kilgore LC, Soong SJ, Gore H, Shingleton HM, Hatch KD, Partridge EE. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol 1988;31:137-53.
6. Kastritis E, Bamias A, Efstathiou E, et al. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy. Gynecol Oncol 2005;99:376-82.
7. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 1995;59:38-44.
8. Kaminski PF, Maier RC. Clear cell adenocarcinoma of the cervix unrelated to diethylstilbestrol exposure. Obstet Gynecol 1983;62:720-7.
9. Greenwald P, Barlow JJ, Nasca PC, Burnett WS. Vaginal cancer after maternal treatment with synthetic estrogens. N Engl J Med 1971;285:390-2.
10. Gilson MD, Dibona DD, Knab DR. Clear cell adenocarcinoma in young females. Obstet Gynecol 1973;41:494-500.
11. Hanselaar A, van Loosbroek M, Schuurbiers O, Heimerhorst T, Bulten J, Bernhelm J. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks. Cancer 1997;79:2229-36.
12. Seki H, Takada T, Sodemoto T, Hoshino H, Saitoh K, Uekusa T. A young woman with clear cell adenocarcinoma of the uterine cervix. Int J Clin Oncol 2003;8:399-404.
13. Waggoner SE, Anderson SM, Van Eyck S, Fuller J, Luce MC, Herbst AL. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol 1994;84:404-8.
14. Waggoner SE, Baunoch DA, Anderson SA, Leigh F, Zagaja VG. Bcl-2 protein expression associated with resistance to apoptosis in clear cell adenocarcinomas of the vagina and cervix expressing wild-type p53. Ann Surg Oncol 1998;5:544-7.
15. Waggoner SE, Anderson SM, Luce MC, Takahashi H, Boyd J. p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol 1996; 60:339-44.
16. Wertheim MS, Hakes TB, Daghestani AN, Nori D, Smith DH, Lewis JL Jr. A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 1985;3:912-6.
17. Kinney WK, Alvarez RD, Reid GC, et al. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study. Gynecol Oncol 1989;34:258-62.
18. Reich O, Tamussino K, Lahousen M, Pickel H, Haas J, Winter R. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol. Gynecol Oncol 2000;76:331-5.